Label: TARON FORTE- iron, calcium ascorbate, cyanocobalamin, and folic acid capsule

  • Category: DIETARY SUPPLEMENT
  • DEA Schedule: None
  • Marketing Status: Dietary Supplement

Drug Label Information

Updated December 22, 2021

If you are a consumer or patient please visit this version.

  • SUPPLEMENT FACTS

    Rev072018

    Taron Forte Multivitamin/Mineral with Iron capsules are indicated for the distinctive nutritional requirements of persons being treated for iron deficiencies by a physician.

  • CONTRAINDICATIONS

    Taron Forte Capsules are contraindicated in patients with a known hypersensitivity to any of the components of this product.

    Hemochromatosis and hemosiderosis are contraindications to iron therapy.

  • WARNINGS

     WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of accidental overdose, call a doctor or poison control center immediately.

  • PRECAUTIONS

    General: The type of anemia and the underlying cause or causes should be determined before starting therapy with Taron Forte Capsules. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.

    Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where B12 is deficient.
    Folic acid in doses above 0.1 mg daily may obscure pernicious anemia assessment, such that hematologic remission can occur while neurological manifestations remain progressive.


    Pediatric Use:
    Safety and effectiveness of this product have not been established in pediatric patients.

  • ADVERSE REACTIONS

    Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools, and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.


    The clinical cause of acute iron overdosage can be variable. Initial symptoms may include: abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock, and coma.

  • DESCRIPTION

    Taron Forte Capsules are orange, imprinted with “TL042”. 

  • DIRECTIONS FOR USE

    One (1) capsule daily or as directed by a physician. 

  • HOW SUPPLIED

    Taron Forte Capsules are packaged in child-resistant bottles of 100 capsules.

    PRODUCT CODE 13811-042-10.

  • STORAGE

    Store at 20°-25°C (68°-77°F), excursion permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Protect from light and moisture.  Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.

  • HEALTH CLAIM

    KEEP OUT OF REACH OF CHILDREN.

    For use on the order of a healthcare practitioner.

    Call your doctor about side effects. To report side effects, call Trigen Laboratories at 1-770-509-4500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

    PLR-TARONFORTE-00001-1                          Rev. 12/2021

    Manufactured for:

    Trigen Laboratories, LLC

    Alpharetta, GA 30005

    TRIGEN LOGO

  • PRINCIPAL DISPLAY PANEL - 100 Capsule Bottle Label

    13811-042-10

    100 Capsules

    Taron Forte
    CAPSULES

    TRIGEN
    LABORATORIES

    Taron Forte BL Rev. 12/2021
  • INGREDIENTS AND APPEARANCE
    TARON FORTE 
    iron, calcium ascorbate, cyanocobalamin, and folic acid capsule
    Product Information
    Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:13811-042
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7) IRON150 mg
    CALCIUM ASCORBATE (UNII: 183E4W213W) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID60 mg
    CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN25 ug
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
    Inactive Ingredients
    Ingredient NameStrength
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    GELATIN (UNII: 2G86QN327L)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    FD&C RED NO. 3 (UNII: PN2ZH5LOQY)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    SHELLAC (UNII: 46N107B71O)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:13811-042-10100 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    DIETARY SUPPLEMENT05/01/2009
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving% Daily Value
    color
    imprint
    scoring1
    shape
    size (solid drugs)22 mm
    Labeler - Trigen Laboratories, LLC (830479668)